Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05362292 · ClinicalTrials.gov registry record · Phase 4
TReating Incontinence for Underlying Mental and Physical Health
A Phase 4 study of Urinary Incontinence and Overactive Bladder, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 270
- Enrollment target
- 2
- Study locations
NCT05362292 is a Phase 4 study of Urinary Incontinence and Overactive Bladder that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 270 participants, roughly in line with the 256-participant average among 48 other Urinary Incontinence trials with a reported enrollment target. The trial reports 2 study locations across 1 state.
The verdict
NCT05362292, a Phase 4 study of Urinary Incontinence and Overactive Bladder, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 270 participants
- Enrollment target
- 2
- Study locations
Study Summary
The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to compare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonist bladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinary incontinence and either normal or mildly impaired cognitive function at baseline.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Mirabegron
- DRUG Tolterodine Tartrate ER
Study Locations (2)
California
- Stanford University - Palo Alto
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2022-10-04 |
| Est. Completion | 2027-08-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05362292
The ClinicalTrials.gov registry entry for NCT05362292 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 256-participant average among 48 other Urinary Incontinence trials with a reported enrollment target. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT05362292 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05362292 about?
NCT05362292 is a clinical study titled "TReating Incontinence for Underlying Mental and Physical Health". The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to compare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonist bladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes i...
What is the current status of trial NCT05362292?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 270 participants. The study started on 2022-10-04. Estimated completion is 2027-08-02.
What conditions does trial NCT05362292 study?
This clinical trial studies the following conditions: Urinary Incontinence, Overactive Bladder, Urinary Incontinence, Urge, Incontinence, Incontinence, Urinary.
What interventions are being tested in trial NCT05362292?
The interventions under investigation include: Placebo (DRUG), Mirabegron (DRUG), Tolterodine Tartrate ER (DRUG).
Who is sponsoring clinical trial NCT05362292?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05362292 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.
COMPLETED · Phase 4
-
Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction
COMPLETED · Phase 4
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.